• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Jul31
Sage Therap released FY2025 Q2 earnings on July 30 (EST), actual revenue USD 31.66 M (forecast USD 16.73 M), actual EPS USD -0.793 (forecast USD -0.9521)
03:00
Jul11
Halper Sadeh Investigating Fairness of Proposed Sage Therapeutics Acquisition
11:51
Jul1
Sage Therapeutics Acquired by Supernus Pharmaceuticals and Laying Off Staff
14:48
Jun17
Truist Financial Raises Sage Therapeutics Target Price to $9
14:58
Halper Sadeh LLC Investigates Sage Therapeutics
01:23
Jun4
Merrill Lynch Cut Its Holdings in Sage Therapeutics
07:04

Schedules & Filings

Schedules
Filings
Jul30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 31.66 M, Net Income -49.65 M, EPS -0.793

Apr29
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 14.06 M, Net Income -62.21 M, EPS -1.0057

Feb11
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 12.82 M, Net Income -95.78 M, EPS -1.5633

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MGRT
13.050
+143.93%
+7.700
PCSA
6.680
+122.30%
+3.675
YCBD
2.270
+58.74%
+0.840
ATPC
0.1408
+56.44%
+0.051
VYNE
0.6000
+48.99%
+0.197
ANDG
23.500
+46.88%
+7.500
ISPO
4.170
+46.83%
+1.330
MDLN
41.000
+41.38%
+12.000
CGTL
1.250
+31.30%
+0.298
GLIBR
8.490
+29.03%
+1.910
View More